Positive update.
Revenue +21% of USD $3.5M is a great outcome. Next quarter will show even stronger customer receipts.
"Following additional sales in the UK and growing adoption in the US, FebriDx® sales continue to grow, with revenue increasing 48% on PCP."
Lots of business activity is going on in the background.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.7¢ | $21.83K | 783.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 373288 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 211609 | 7 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |